GlassScriptPhysician profile
Ethan Charles Levin
NPI 1326332123
$854.67
in general payments reported to CMS, 2019-2025
18 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $68.69 · 2021: $77.80 · 2022: $56.40 · 2023: $56.23 · 2024: $175 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $213.28 | 2019-2025 | |
| Amgen INC. | $110.08 | 2019-2024 | Otezla |
| Lilly USA, LLC | $68.18 | 2019-2025 | Taltz, Ebglyss, Adcirca |
| E.R. Squibb & Sons, L.L.C. | $63.55 | 2022-2025 | Sotyktu |
| Strata Skin Sciences, INC. | $62.74 | 2024-2025 | Xtrac |
| Convatec INC. | $39.12 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $39.09 | 2019 | |
| Sun Pharmaceutical Industries INC. | $36.54 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.93 | 2019 | |
| Kerecis Limited | $31.87 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Genzyme Corporation | $24.42 | 2023 | |
| Janssen Biotech, INC. | $23.30 | 2021 | |
| Reprise Biomedical, INC. | $22.82 | 2025 | Miro3d |
| Mimedx Group, INC. | $19.70 | 2024 | |
| Allergan, INC. | $18.82 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $17.42 | 2024 | |
| Leo Pharma INC. | $16.36 | 2019 | |
| Abbvie INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.